Literature DB >> 21962294

Combining stem cells and genes for effective therapeutics.

Zhaoyang Ye, Ram I Mahato.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21962294      PMCID： PMC3207237          DOI： 10.1021/mp200437m

Source DB:  PubMed          Journal:  Mol Pharm        ISSN： 1543-8384            Impact factor:   4.939


× No keyword cloud information.
  15 in total

Review 1.  Stem cell based cancer gene therapy.

Authors:  Marina Cihova; Veronika Altanerova; Cestmir Altaner
Journal:  Mol Pharm       Date:  2011-07-25       Impact factor: 4.939

2.  A comparative study of neural and mesenchymal stem cell-based carriers for oncolytic adenovirus in a model of malignant glioma.

Authors:  Atique U Ahmed; Matthew A Tyler; Bart Thaci; Nikita G Alexiades; Yu Han; Ilya V Ulasov; Maciej S Lesniak
Journal:  Mol Pharm       Date:  2011-06-30       Impact factor: 4.939

Review 3.  Hematopoietic stem cell gene therapy as a treatment for autoimmune diseases.

Authors:  Frank Alderuccio; Zeyad Nasa; Jieyu Chung; Hyun-Ja Ko; James Chan; Ban-Hock Toh
Journal:  Mol Pharm       Date:  2011-07-13       Impact factor: 4.939

Review 4.  Genetically modified mesenchymal stem cells for improved islet transplantation.

Authors:  Hao Wu; Zhaoyang Ye; Ram I Mahato
Journal:  Mol Pharm       Date:  2011-07-07       Impact factor: 4.939

5.  Biosafety assessment of human mesenchymal stem cells engineered by hybrid baculovirus vectors.

Authors:  Chi-Yuan Chen; Hsiao-Hsuan Wu; Chih-Ping Chen; Schu-Rern Chern; Shiaw-Min Hwang; Shiu-Feng Huang; Wen-Hsin Lo; Guan-Yu Chen; Yu-Chen Hu
Journal:  Mol Pharm       Date:  2011-01-18       Impact factor: 4.939

6.  Development of novel efficient SIN vectors with improved safety features for Wiskott-Aldrich syndrome stem cell based gene therapy.

Authors:  Inés Avedillo Díez; Daniela Zychlinski; Emanuele G Coci; Melanie Galla; Ute Modlich; Ricardo A Dewey; Adrian Schwarzer; Tobias Maetzig; Nonsikelelo Mpofu; Elmar Jaeckel; Kaan Boztug; Christopher Baum; Christoph Klein; Axel Schambach
Journal:  Mol Pharm       Date:  2011-08-31       Impact factor: 4.939

7.  Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease.

Authors:  M Cavazzana-Calvo; S Hacein-Bey; G de Saint Basile; F Gross; E Yvon; P Nusbaum; F Selz; C Hue; S Certain; J L Casanova; P Bousso; F L Deist; A Fischer
Journal:  Science       Date:  2000-04-28       Impact factor: 47.728

8.  Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.

Authors:  Mariana G Garcia; Juan Bayo; Marcela F Bolontrade; Leonardo Sganga; Mariana Malvicini; Laura Alaniz; Jorge B Aquino; Esteban Fiore; Manglio M Rizzo; Andrés Rodriguez; Alicia Lorenti; Oscar Andriani; Osvaldo Podhajcer; Guillermo Mazzolini
Journal:  Mol Pharm       Date:  2011-08-19       Impact factor: 4.939

9.  Gene therapy for immunodeficiency due to adenosine deaminase deficiency.

Authors:  Alessandro Aiuti; Federica Cattaneo; Stefania Galimberti; Ulrike Benninghoff; Barbara Cassani; Luciano Callegaro; Samantha Scaramuzza; Grazia Andolfi; Massimiliano Mirolo; Immacolata Brigida; Antonella Tabucchi; Filippo Carlucci; Martha Eibl; Memet Aker; Shimon Slavin; Hamoud Al-Mousa; Abdulaziz Al Ghonaium; Alina Ferster; Andrea Duppenthaler; Luigi Notarangelo; Uwe Wintergerst; Rebecca H Buckley; Marco Bregni; Sarah Marktel; Maria Grazia Valsecchi; Paolo Rossi; Fabio Ciceri; Roberto Miniero; Claudio Bordignon; Maria-Grazia Roncarolo
Journal:  N Engl J Med       Date:  2009-01-29       Impact factor: 91.245

10.  Genetic control of wayward pluripotent stem cells and their progeny after transplantation.

Authors:  Maija Kiuru; Julie L Boyer; Timothy P O'Connor; Ronald G Crystal
Journal:  Cell Stem Cell       Date:  2009-04-03       Impact factor: 24.633
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.